{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:35:05Z","timestamp":1788942905035,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Radiolabeled fibroblast activation protein inhibitor (FAPI) is considered as a potential alternative agent to <jats:sup>18<\/jats:sup>F-FDG for tumor-specific imaging. We report <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>68<\/jats:sup>Ga-FAPI-04 PET\/MR findings in a 67-year-old woman with gallbladder adenocarcinoma. The lesions showed intense <jats:sup>18<\/jats:sup>F-FDG uptake but limited <jats:sup>68<\/jats:sup>Ga-FAPI-04 uptake in PET\/MR. This case emphasizes the necessity for nuclear clinicians to exercise caution when assessing gallbladder lesions with limited <jats:sup>68<\/jats:sup>Ga-FAPI-04 uptake, underscoring the continued relevance of <jats:sup>18<\/jats:sup>F-FDG in this diagnostic domain.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005182","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T15:31:23Z","timestamp":1711467083000},"page":"540-542","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Positive 18F-FDG and Negative 68Ga-FAPI-04 Findings in a Patient With Gallbladder Adenocarcinoma"],"prefix":"10.1097","volume":"49","author":[{"given":"Na","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengbei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"bib1-20250621","first-page":"273","article-title":"Early diagnosis of primary gallbladder carcinoma","volume":"1","year":"2002","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MNM.0000000000001494","article-title":"Clinical and metabolic parameters for predicting disease progression of gallbladder adenocarcinoma","volume":"43","year":"2022","journal-title":"Nucl Med Commun"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e194003","DOI":"10.1148\/rycan.2019194003","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"1","year":"2019","journal-title":"Radiol Imaging Cancer"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]F-FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.7150\/thno.69475","article-title":"Fibroblast activation protein\u2013based theranostics in cancer research: a state-of-the-art review","volume":"12","year":"2022","journal-title":"Theranostics"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/RLU.0000000000004424","article-title":"Increased 68Ga-FAPI uptake in psammomatous meningioma in a patient with gallbladder cancer","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13139-022-00763-5","article-title":"The superiority of 68Ga-FAPI-04 over 18F-FDG in a case of gallbladder cancer","volume":"56","year":"2022","journal-title":"Nucl Med Mol Imaging"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1097\/RLU.0000000000004601","article-title":"Superiority of 18F-FDG PET\/CT to 68Ga-FAPI PET\/CT in adrenocortical tumor imaging","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1097\/RLU.0000000000004871","article-title":"Complete absence of FAPI uptake in a patient with aggressive diffuse large B-cell lymphoma involving multiple nodal and extranodal sites","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1097\/RLU.0000000000004704","article-title":"FAPI-negative FDG-avid metastatic relapse of breast cancer on PET\/CT","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/RLU.0000000000004955","article-title":"FAPI uptake in gallbladder is it normal biodistribution?","volume":"49","year":"2024","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/RLU.0000000000004248","article-title":"Xanthogranulomatous cholecystitis masquerading as gallbladder carcinoma on 68Ga-FAPI-04 PET","volume":"47","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:57Z","timestamp":1750532757000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005182","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,25]]}}}